The Ohio State University Dermatology Biorepository
ConditionHidradenitis Suppurativa
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorOhio State University
About this trial
This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Seen by an Ohio State University (OSU) Dermatology provider on the main University Hospital campus, including the James Cancer Hospital, OSU Dermatology East, OSU Dermatology at the Ohio State Eye and Ear Institute, Martha Morehouse Medical Pavilion, and OSU Dermatology at Upper Arlington after the date of approval of this protocol
Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals
Willingness to participate in a research study.
Disqualifiers
Inability to provide informed consent
Trial population
Any person that meets the inclusion/exclusion criteria
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Source of clinical specimens for the future study of neoplastic and inflammatory skin disorders
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov